abstract |
The present specification relates to an anti-inflammatory composition containing a novel quercetin compound isolated from post-fermented tea, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof. It can be widely used in related fields. [Selection diagram] Figure 1 |